Sanofi gets rated buy today, agreeing with bullish ratings from the Wall Street and SA analysts' consensus. With a diverse ...

Sanofi (SNY) has released an update ... TipRanks' multi-award winning platform ranks financial experts based on measured performance and the accuracy of their predictions so investors know ...

View upcoming earnings forecasts and in-depth analysis of company forecasts.

the French state and CD&R and was approved by Sanofi’s board on Sunday, the newspaper said. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news ...

Novavax has made a smaller splash in the U.S. Covid-19 vaccine market than it had hoped. But it's betting on licensing deals ...

Sanofi (NASDAQ:SNY – Free Report) by 30.4% during the third quarter, according to the company in its most recent filing with ...

Sanofi is scheduled to report results for the third quarter on ... Dow Jones Newswires Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers ...

Vir Biotechnology, Inc. ( (VIR) ) has released its Q3 earnings. Here is a breakdown of the information Vir Biotechnology, Inc. presented to its ...

Further boosting the pipeline, mid-stage drugs like Sanofi/Regeneron’s itepekimab ... will be presented in 23 abstracts at ...

Yuichi Iwaki, M.D., Ph.D., MediciNova CEO commented, “The successful resolution of the Sanofi-Novartis litigation and the resulting monetary damages due to MediciNova both validates the value of our ...

Vir Biotechnology, Inc. (Nasdaq: VIR) today provided a corporate update and reported financial results for the third quarter ...